TG Therapeutics, Inc. - TGTX

SEC FilingsOur TGTX Tweets

About Gravity Analytica

Recent News

  • 04.10.2025 - TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
  • 04.10.2025 - TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
  • 04.10.2025 - TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
  • 04.08.2025 - TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
  • 04.08.2025 - TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
  • 04.08.2025 - TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
  • 04.07.2025 - TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
  • 04.07.2025 - TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
  • 04.07.2025 - TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals
  • 03.07.2025 - TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

Recent Filings

  • 03.18.2025 - 4 Statement of changes in beneficial ownership of securities
  • 03.11.2025 - 4 Statement of changes in beneficial ownership of securities
  • 03.03.2025 - EX-99.1 EX-99.1